High‐frequency autonomic modulation: a new model for analysis of autonomic cardiac control

Background and Purpose Increase in high‐frequency beat‐to‐beat heart rate oscillations by torsadogenic hERG blockers appears to be associated with signs of parasympathetic and sympathetic co‐activation which cannot be assessed directly using classic methods of heart rate variability analysis. The pr...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of pharmacology Vol. 175; no. 15; pp. 3131 - 3143
Main Authors Champéroux, Pascal, Fesler, Pierre, Judé, Sebastien, Richard, Serge, Le Guennec, Jean‐Yves, Thireau, Jérôme
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.08.2018
Wiley
John Wiley and Sons Inc
Subjects
Online AccessGet full text
ISSN0007-1188
1476-5381
1476-5381
DOI10.1111/bph.14354

Cover

Abstract Background and Purpose Increase in high‐frequency beat‐to‐beat heart rate oscillations by torsadogenic hERG blockers appears to be associated with signs of parasympathetic and sympathetic co‐activation which cannot be assessed directly using classic methods of heart rate variability analysis. The present work aimed to find a translational model that would allow this particular state of the autonomic control of heart rate to be assessed. Experimental Approach High‐frequency heart rate and heart period oscillations were analysed within discrete 10 s intervals in a cohort of 200 healthy human subjects. Results were compared to data collected in non‐human primates and beagle dogs during pharmacological challenges and torsadogenic hERG blockers exposure, in 127 genotyped LQT1 patients on/off β‐blocker treatment and in subgroups of smoking and non‐smoking subjects. Key Results Three states of autonomic modulation, S1 (parasympathetic predominance) to S3 (reciprocal parasympathetic withdrawal/sympathetic activation), were differentiated to build a new model of heart rate variability referred to as high‐frequency autonomic modulation. The S2 state corresponded to a specific state during which both parasympathetic and sympathetic systems were coexisting or co‐activated. S2 oscillations were proportionally increased by torsadogenic hERG‐blocking drugs, whereas smoking caused an increase in S3 oscillations. Conclusions and Implications The combined analysis of the magnitude of high‐frequency heart rate and high‐frequency heart period oscillations allows a refined assessment of heart rate autonomic modulation applicable to long‐term ECG recordings and offers new approaches to assessment of the risk of sudden death both in terms of underlying mechanisms and sensitivity.
AbstractList Increase in high-frequency beat-to-beat heart rate oscillations by torsadogenic hERG blockers appears to be associated with signs of parasympathetic and sympathetic co-activation which cannot be assessed directly using classic methods of heart rate variability analysis. The present work aimed to find a translational model that would allow this particular state of the autonomic control of heart rate to be assessed. High-frequency heart rate and heart period oscillations were analysed within discrete 10 s intervals in a cohort of 200 healthy human subjects. Results were compared to data collected in non-human primates and beagle dogs during pharmacological challenges and torsadogenic hERG blockers exposure, in 127 genotyped LQT1 patients on/off β-blocker treatment and in subgroups of smoking and non-smoking subjects. Three states of autonomic modulation, S1 (parasympathetic predominance) to S3 (reciprocal parasympathetic withdrawal/sympathetic activation), were differentiated to build a new model of heart rate variability referred to as high-frequency autonomic modulation. The S2 state corresponded to a specific state during which both parasympathetic and sympathetic systems were coexisting or co-activated. S2 oscillations were proportionally increased by torsadogenic hERG-blocking drugs, whereas smoking caused an increase in S3 oscillations. The combined analysis of the magnitude of high-frequency heart rate and high-frequency heart period oscillations allows a refined assessment of heart rate autonomic modulation applicable to long-term ECG recordings and offers new approaches to assessment of the risk of sudden death both in terms of underlying mechanisms and sensitivity.
Increase in high-frequency beat-to-beat heart rate oscillations by torsadogenic hERG blockers appears to be associated with signs of parasympathetic and sympathetic co-activation which cannot be assessed directly using classic methods of heart rate variability analysis. The present work aimed to find a translational model that would allow this particular state of the autonomic control of heart rate to be assessed.BACKGROUND AND PURPOSEIncrease in high-frequency beat-to-beat heart rate oscillations by torsadogenic hERG blockers appears to be associated with signs of parasympathetic and sympathetic co-activation which cannot be assessed directly using classic methods of heart rate variability analysis. The present work aimed to find a translational model that would allow this particular state of the autonomic control of heart rate to be assessed.High-frequency heart rate and heart period oscillations were analysed within discrete 10 s intervals in a cohort of 200 healthy human subjects. Results were compared to data collected in non-human primates and beagle dogs during pharmacological challenges and torsadogenic hERG blockers exposure, in 127 genotyped LQT1 patients on/off β-blocker treatment and in subgroups of smoking and non-smoking subjects.EXPERIMENTAL APPROACHHigh-frequency heart rate and heart period oscillations were analysed within discrete 10 s intervals in a cohort of 200 healthy human subjects. Results were compared to data collected in non-human primates and beagle dogs during pharmacological challenges and torsadogenic hERG blockers exposure, in 127 genotyped LQT1 patients on/off β-blocker treatment and in subgroups of smoking and non-smoking subjects.Three states of autonomic modulation, S1 (parasympathetic predominance) to S3 (reciprocal parasympathetic withdrawal/sympathetic activation), were differentiated to build a new model of heart rate variability referred to as high-frequency autonomic modulation. The S2 state corresponded to a specific state during which both parasympathetic and sympathetic systems were coexisting or co-activated. S2 oscillations were proportionally increased by torsadogenic hERG-blocking drugs, whereas smoking caused an increase in S3 oscillations.KEY RESULTSThree states of autonomic modulation, S1 (parasympathetic predominance) to S3 (reciprocal parasympathetic withdrawal/sympathetic activation), were differentiated to build a new model of heart rate variability referred to as high-frequency autonomic modulation. The S2 state corresponded to a specific state during which both parasympathetic and sympathetic systems were coexisting or co-activated. S2 oscillations were proportionally increased by torsadogenic hERG-blocking drugs, whereas smoking caused an increase in S3 oscillations.The combined analysis of the magnitude of high-frequency heart rate and high-frequency heart period oscillations allows a refined assessment of heart rate autonomic modulation applicable to long-term ECG recordings and offers new approaches to assessment of the risk of sudden death both in terms of underlying mechanisms and sensitivity.CONCLUSIONS AND IMPLICATIONSThe combined analysis of the magnitude of high-frequency heart rate and high-frequency heart period oscillations allows a refined assessment of heart rate autonomic modulation applicable to long-term ECG recordings and offers new approaches to assessment of the risk of sudden death both in terms of underlying mechanisms and sensitivity.
Background and PurposeIncrease in high‐frequency beat‐to‐beat heart rate oscillations by torsadogenic hERG blockers appears to be associated with signs of parasympathetic and sympathetic co‐activation which cannot be assessed directly using classic methods of heart rate variability analysis. The present work aimed to find a translational model that would allow this particular state of the autonomic control of heart rate to be assessed.Experimental ApproachHigh‐frequency heart rate and heart period oscillations were analysed within discrete 10 s intervals in a cohort of 200 healthy human subjects. Results were compared to data collected in non‐human primates and beagle dogs during pharmacological challenges and torsadogenic hERG blockers exposure, in 127 genotyped LQT1 patients on/off β‐blocker treatment and in subgroups of smoking and non‐smoking subjects.Key ResultsThree states of autonomic modulation, S1 (parasympathetic predominance) to S3 (reciprocal parasympathetic withdrawal/sympathetic activation), were differentiated to build a new model of heart rate variability referred to as high‐frequency autonomic modulation. The S2 state corresponded to a specific state during which both parasympathetic and sympathetic systems were coexisting or co‐activated. S2 oscillations were proportionally increased by torsadogenic hERG‐blocking drugs, whereas smoking caused an increase in S3 oscillations.Conclusions and ImplicationsThe combined analysis of the magnitude of high‐frequency heart rate and high‐frequency heart period oscillations allows a refined assessment of heart rate autonomic modulation applicable to long‐term ECG recordings and offers new approaches to assessment of the risk of sudden death both in terms of underlying mechanisms and sensitivity.
Background and Purpose Increase in high‐frequency beat‐to‐beat heart rate oscillations by torsadogenic hERG blockers appears to be associated with signs of parasympathetic and sympathetic co‐activation which cannot be assessed directly using classic methods of heart rate variability analysis. The present work aimed to find a translational model that would allow this particular state of the autonomic control of heart rate to be assessed. Experimental Approach High‐frequency heart rate and heart period oscillations were analysed within discrete 10 s intervals in a cohort of 200 healthy human subjects. Results were compared to data collected in non‐human primates and beagle dogs during pharmacological challenges and torsadogenic hERG blockers exposure, in 127 genotyped LQT1 patients on/off β‐blocker treatment and in subgroups of smoking and non‐smoking subjects. Key Results Three states of autonomic modulation, S1 (parasympathetic predominance) to S3 (reciprocal parasympathetic withdrawal/sympathetic activation), were differentiated to build a new model of heart rate variability referred to as high‐frequency autonomic modulation. The S2 state corresponded to a specific state during which both parasympathetic and sympathetic systems were coexisting or co‐activated. S2 oscillations were proportionally increased by torsadogenic hERG‐blocking drugs, whereas smoking caused an increase in S3 oscillations. Conclusions and Implications The combined analysis of the magnitude of high‐frequency heart rate and high‐frequency heart period oscillations allows a refined assessment of heart rate autonomic modulation applicable to long‐term ECG recordings and offers new approaches to assessment of the risk of sudden death both in terms of underlying mechanisms and sensitivity.
Author Champéroux, Pascal
Fesler, Pierre
Thireau, Jérôme
Judé, Sebastien
Le Guennec, Jean‐Yves
Richard, Serge
AuthorAffiliation 1 Centre de Recherches Biologiques, CERB Baugy 18800 France
3 Laboratoire PHYMEDEXP,INSERM U1046, CNRS UMR 9214 Université de Montpellier, CHU Arnaud de Villeneuve Montpellier Cedex 05 34295 France
2 Department of Internal Medicine Hopital Lapeyronie Montpellier France
AuthorAffiliation_xml – name: 1 Centre de Recherches Biologiques, CERB Baugy 18800 France
– name: 2 Department of Internal Medicine Hopital Lapeyronie Montpellier France
– name: 3 Laboratoire PHYMEDEXP,INSERM U1046, CNRS UMR 9214 Université de Montpellier, CHU Arnaud de Villeneuve Montpellier Cedex 05 34295 France
Author_xml – sequence: 1
  givenname: Pascal
  orcidid: 0000-0001-8175-1452
  surname: Champéroux
  fullname: Champéroux, Pascal
  email: pascal.champeroux@cerb.fr
  organization: Centre de Recherches Biologiques, CERB
– sequence: 2
  givenname: Pierre
  surname: Fesler
  fullname: Fesler, Pierre
  organization: Université de Montpellier, CHU Arnaud de Villeneuve
– sequence: 3
  givenname: Sebastien
  surname: Judé
  fullname: Judé, Sebastien
  organization: Centre de Recherches Biologiques, CERB
– sequence: 4
  givenname: Serge
  surname: Richard
  fullname: Richard, Serge
  organization: Centre de Recherches Biologiques, CERB
– sequence: 5
  givenname: Jean‐Yves
  surname: Le Guennec
  fullname: Le Guennec, Jean‐Yves
  organization: Université de Montpellier, CHU Arnaud de Villeneuve
– sequence: 6
  givenname: Jérôme
  surname: Thireau
  fullname: Thireau, Jérôme
  organization: Université de Montpellier, CHU Arnaud de Villeneuve
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29723392$$D View this record in MEDLINE/PubMed
https://hal.umontpellier.fr/hal-01785431$$DView record in HAL
BookMark eNp9kk1rFDEYx4NU7Lb14BeQAS96mDavM1kPQi3WFRb0UG9CyOSlm5JJ1mSmZW9-BD-jn6SZbq11QXN5IM_v_7wfgL0QgwHgBYLHqLyTbr06RpQw-gTMEG2bmhGO9sAMQtjWCHG-Dw5yvoKwOFv2DOzjeYsJmeMZ-LZwl6tfP37aZL6PJqhNJcchhtg7VfVRj14OLoa3layCuZl-jK9sTJUM0m-yy1W0jxRKJu1ksTEMKfoj8NRKn83ze3sIvp5_uDhb1MvPHz-dnS5rVeqhtVEWN1xqq6QmsEHU2NJExyhsO027ThNtuGqINbpjWCrLiDJzqzo8Zy3jhhyCd9u467HrjVamZJderJPrZdqIKJ342xPcSlzGa9FAgnhLSoA32wCrHdnidCmmP4hazihB16iwr--TpVhGlgfRu6yM9zKYOGaBIWG4oBwX9NUOehXHVCY3UU1pj3E6US8fV_-Q__eS_lSnUsw5GfuAICimAxDlAMTdART2ZIdVbrjbYWnc-f8pbpw3m3-HFu-_LLaKW8aNw7k
CitedBy_id crossref_primary_10_1007_s10072_021_05621_4
crossref_primary_10_1016_j_vascn_2024_107512
crossref_primary_10_3390_life12101659
crossref_primary_10_1038_s41598_022_12844_8
crossref_primary_10_1016_j_vascn_2023_107266
crossref_primary_10_1002_smi_3373
crossref_primary_10_1016_j_vascn_2023_107268
crossref_primary_10_2196_16654
crossref_primary_10_3390_biology11040603
crossref_primary_10_1111_jsr_13920
crossref_primary_10_1016_j_amcp_2024_09_005
crossref_primary_10_1016_j_isci_2021_103688
crossref_primary_10_25259_IJPP_553_2022
crossref_primary_10_1016_j_acvd_2024_05_097
crossref_primary_10_1111_bph_15905
Cites_doi 10.1037/0033-295X.98.4.459
10.3389/fphys.2011.00086
10.1037/0735-7044.102.1.66
10.1111/bph.13093
10.1111/j.1476-5381.2010.00872.x
10.1126/science.6166045
10.1152/jappl.1993.75.5.2310
10.1016/j.ejpain.2010.11.011
10.1093/nar/gkx1121
10.1016/j.hrthm.2016.02.006
10.1016/j.jelectrocard.2012.08.001
10.1016/j.jacc.2007.03.045
10.1111/bph.13878
10.1161/01.CIR.93.5.1043
10.1097/00005344-199805000-00010
10.1111/bph.13391
10.1111/bph.14153
10.1161/01.CIR.100.1.27
10.1111/bph.12955
10.1088/0967-3334/15/2/006
10.1016/0002-9149(94)90400-6
10.2337/dc11-2120
10.1111/bph.13884
10.1161/STROKEAHA.110.607721
10.1161/01.CIR.0000047275.25795.17
10.1152/japplphysiol.00446.2006
10.1161/01.CIR.94.11.2850
10.1093/europace/euv015
10.1016/j.hrthm.2010.09.011
ContentType Journal Article
Copyright 2018 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.
2018 The British Pharmacological Society
Distributed under a Creative Commons Attribution 4.0 International License
Copyright_xml – notice: 2018 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.
– notice: 2018 The British Pharmacological Society
– notice: Distributed under a Creative Commons Attribution 4.0 International License
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7TK
K9.
NAPCQ
7X8
1XC
VOOES
5PM
DOI 10.1111/bph.14354
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
Hyper Article en Ligne (HAL)
Hyper Article en Ligne (HAL) (Open Access)
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
ProQuest Health & Medical Complete (Alumni)

Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
DocumentTitleAlternate High‐frequency autonomic modulation
EISSN 1476-5381
EndPage 3143
ExternalDocumentID PMC6031873
oai_HAL_hal_01785431v1
29723392
10_1111_bph_14354
BPH14354
Genre article
Journal Article
GroupedDBID ---
.3N
.55
.GJ
05W
0R~
1OC
23N
24P
2WC
31~
33P
36B
3O-
3SF
4.4
52U
52V
53G
5GY
6J9
7RV
7X7
8-0
8-1
88E
8AO
8FE
8FH
8FI
8FJ
8R4
8R5
8UM
AAESR
AAEVG
AAFWJ
AAHQN
AAIPD
AAMMB
AAMNL
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCUV
ABDBF
ABPVW
ABQWH
ABUWG
ABXGK
ACAHQ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACUHS
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEFGJ
AEGXH
AEIGN
AEIMD
AENEX
AEUYR
AEYWJ
AFBPY
AFFPM
AFGKR
AFKRA
AFRAH
AFWVQ
AFZJQ
AGHNM
AGXDD
AGYGG
AHBTC
AHMBA
AIACR
AIAGR
AIDQK
AIDYY
AITYG
AIURR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
AOIJS
ATUGU
AZBYB
AZVAB
B0M
BAFTC
BAWUL
BBNVY
BENPR
BFHJK
BHBCM
BHPHI
BKEYQ
BMXJE
BPHCQ
BRXPI
BVXVI
C45
CAG
CCPQU
COF
CS3
DCZOG
DIK
DRFUL
DRMAN
DRSTM
DU5
E3Z
EAD
EAP
EAS
EBC
EBD
EBS
ECV
EJD
EMB
EMK
EMOBN
ENC
ESX
EX3
F5P
FUBAC
FYUFA
G-S
GODZA
GX1
H.X
HCIFZ
HGLYW
HMCUK
HYE
HZ~
J5H
KBYEO
LATKE
LEEKS
LH4
LITHE
LK8
LOXES
LSO
LUTES
LW6
LYRES
M1P
M7P
MEWTI
MK0
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
MY~
N9A
NAPCQ
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
Q.N
Q2X
QB0
ROL
RPM
SJN
SUPJJ
SV3
TEORI
TR2
TUS
UKHRP
UPT
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WVDHM
WXSBR
X7M
XV2
Y6R
YHG
ZGI
ZXP
ZZTAW
~8M
~S-
AAHHS
AAYXX
ACCFJ
ADZOD
AEEZP
AEQDE
AIWBW
AJBDE
ALIPV
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7TK
K9.
1OB
7X8
1XC
VOOES
5PM
ID FETCH-LOGICAL-c4774-ecf268adfcad30614ef476b5407bd4bbd3de8c63fedb52acf53ce9fcb295758e3
IEDL.DBID 24P
ISSN 0007-1188
1476-5381
IngestDate Thu Aug 21 18:28:39 EDT 2025
Tue Jun 17 06:53:22 EDT 2025
Fri Sep 05 06:28:01 EDT 2025
Fri Jul 25 09:26:03 EDT 2025
Thu Apr 03 07:02:29 EDT 2025
Tue Jul 01 03:00:36 EDT 2025
Thu Apr 24 22:58:54 EDT 2025
Wed Aug 20 07:26:39 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 15
Keywords heart rate variability
power spectral analysis
autonomic nervous system
Language English
License Attribution-NonCommercial
2018 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.
Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4774-ecf268adfcad30614ef476b5407bd4bbd3de8c63fedb52acf53ce9fcb295758e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Equal contribution as senior authors.
ORCID 0000-0001-8175-1452
0000-0002-7831-6545
0000-0001-8791-4208
0000-0002-1641-5142
OpenAccessLink https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fbph.14354
PMID 29723392
PQID 2064075842
PQPubID 42104
PageCount 13
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6031873
hal_primary_oai_HAL_hal_01785431v1
proquest_miscellaneous_2035243182
proquest_journals_2064075842
pubmed_primary_29723392
crossref_primary_10_1111_bph_14354
crossref_citationtrail_10_1111_bph_14354
wiley_primary_10_1111_bph_14354_BPH14354
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate August 2018
PublicationDateYYYYMMDD 2018-08-01
PublicationDate_xml – month: 08
  year: 2018
  text: August 2018
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
– name: Hoboken
PublicationTitle British journal of pharmacology
PublicationTitleAlternate Br J Pharmacol
PublicationYear 2018
Publisher Blackwell Publishing Ltd
Wiley
John Wiley and Sons Inc
Publisher_xml – name: Blackwell Publishing Ltd
– name: Wiley
– name: John Wiley and Sons Inc
References 2015; 17
2011; 2
1991; 98
1996; 94
1988; 102
1996; 93
2007; 50
2011; 15
1999; 100
2010; 160
2012; 35
2016; 13
2017a; 174
2018; 46
2018; 175
2015; 172
2003; 107
1981; 213
2017b; 174
1993; 75
2011; 42
1994; 15
2012; 45
1998; 31
2010; 7
2006; 101
1994; 74
2016; 173
e_1_2_10_23_1
e_1_2_10_24_1
e_1_2_10_21_1
e_1_2_10_22_1
e_1_2_10_20_1
e_1_2_10_2_1
e_1_2_10_4_1
e_1_2_10_18_1
e_1_2_10_3_1
e_1_2_10_19_1
e_1_2_10_6_1
e_1_2_10_16_1
e_1_2_10_5_1
e_1_2_10_17_1
e_1_2_10_8_1
e_1_2_10_14_1
e_1_2_10_7_1
e_1_2_10_15_1
e_1_2_10_12_1
e_1_2_10_9_1
e_1_2_10_13_1
e_1_2_10_10_1
e_1_2_10_11_1
e_1_2_10_30_1
e_1_2_10_29_1
e_1_2_10_27_1
e_1_2_10_28_1
e_1_2_10_25_1
e_1_2_10_26_1
References_xml – volume: 98
  start-page: 459
  year: 1991
  end-page: 487
  article-title: Autonomic determinism: the modes of autonomic control, the doctrine of autonomic space, and the laws of autonomic constraint
  publication-title: Psychol Rev
– volume: 93
  start-page: 1043
  year: 1996
  end-page: 1065
  article-title: Heart rate variability: standards of measurement, physiological interpretation, and clinical use
  publication-title: Circulation
– volume: 174
  start-page: S17
  year: 2017b
  end-page: S129
  article-title: The Concise Guide to PHARMACOLOGY 2017/18: G protein‐coupled receptors
  publication-title: Br J Pharmacol
– volume: 75
  start-page: 2310
  year: 1993
  end-page: 2317
  article-title: Important influence of respiration on human R‐R interval power spectra is largely ignored
  publication-title: J Appl Physiol
– volume: 46
  start-page: D1091
  year: 2018
  end-page: D1106
  article-title: The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
  publication-title: Nucl Acids Res
– volume: 102
  start-page: 66
  year: 1988
  end-page: 76
  article-title: Dissociation of associative and nonassociative concomitants of classical fear conditioning in the freely behaving rat
  publication-title: Behav Neurosci
– volume: 2
  start-page: 1
  year: 2011
  end-page: 13
  article-title: Heart rate variability – a historical perspective
  publication-title: Front Physiol
– volume: 7
  start-page: 1797
  year: 2010
  end-page: 1805
  article-title: Trigger‐specific risk factors and response to therapy in long QT syndrome type 2
  publication-title: Heart Rhythm
– volume: 15
  start-page: 554
  year: 2011
  end-page: 560
  article-title: Autonomic pain responses during sleep: a study of heart rate variability
  publication-title: Eur J Pain
– volume: 100
  start-page: 27
  year: 1999
  end-page: 32
  article-title: Muscle metaboreflex contribution to sinus node regulation during static exercise: insights from spectral analysis of heart rate variability
  publication-title: Circulation
– volume: 74
  start-page: 340
  year: 1994
  end-page: 345
  article-title: Effects of beta blockers (atenolol or metoprolol) on heart rate variability after acute myocardial infarction
  publication-title: Am J Cardiol
– volume: 45
  start-page: 677
  year: 2012
  end-page: 683
  article-title: The Telemetric and Holter ECG Warehouse (THEW): the first three years of development and research
  publication-title: J Electrocardiol
– volume: 94
  start-page: 2850
  year: 1996
  end-page: 2855
  article-title: Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study
  publication-title: Circulation
– volume: 101
  start-page: 676
  year: 2006
  end-page: 682
  article-title: Point: counterpoint: cardiovascular variability is/is not an index of autonomic control of circulation
  publication-title: J Appl Physiol
– volume: 31
  start-page: 714
  year: 1998
  end-page: 720
  article-title: Autonomic effects of nicotine patch administration in habitual cigarette smokers: a double‐blind, placebo‐controlled study using spectral analysis of RR interval and systolic arterial pressure variabilities
  publication-title: J Cardiovasc Pharmacol
– volume: 172
  start-page: 3189
  year: 2015
  end-page: 3193
  article-title: Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP
  publication-title: Br J Pharmacol
– volume: 50
  start-page: 335
  year: 2007
  end-page: 343
  article-title: Left stellate ganglion and vagal nerve activity and cardiac arrhythmias in ambulatory dogs with pacing‐induced congestive heart failure
  publication-title: J Am Coll Cardiol
– volume: 13
  start-page: 1309
  year: 2016
  end-page: 1316
  article-title: Reference values for time‐ and frequency‐domain heart rate variability measures
  publication-title: Heart Rhythm
– volume: 15
  start-page: 163
  year: 1994
  end-page: 179
  article-title: The accuracy of power‐spectrum analysis of heart‐rate variability from annotated RR list generated by Holter systems
  publication-title: Physiol Meas
– volume: 172
  start-page: 2878
  year: 2015
  end-page: 2891
  article-title: Dofetilide induced QT interval short term variability and ventricular arrhythmias are dependent on high frequency autonomic oscillations
  publication-title: Br J Pharmacol
– volume: 213
  start-page: 220
  year: 1981
  end-page: 222
  article-title: Power spectrum analysis of heart rate fluctuations: a quantitative probe of beat‐to‐beat cardiovascular control
  publication-title: Science
– volume: 107
  start-page: 565
  year: 2003
  end-page: 570
  article-title: Short‐term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients
  publication-title: Circulation
– volume: 175
  start-page: 987
  year: 2018
  end-page: 993
  article-title: Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers
  publication-title: Brit J Pharmacol
– volume: 160
  start-page: 1577
  year: 2010
  end-page: 1579
  article-title: NC3Rs reporting guidelines working group. Animal research: reporting in vivo experiments: the ARRIVE guidelines
  publication-title: Br J Pharmacol
– volume: 173
  start-page: 601
  year: 2016
  end-page: 612
  article-title: The high frequency relationship: implications for torsadogenic hERG blockers
  publication-title: Br J Pharmacol
– volume: 174
  start-page: S160
  year: 2017a
  end-page: S194
  article-title: The Concise Guide to PHARMACOLOGY 2017/18: Voltage‐gated ion channels
  publication-title: Br J Pharmacol
– volume: 17
  start-page: 1341
  year: 2015
  end-page: 1353
  article-title: Advances in heart rate variability signal analysis: joint position statement by the e‐Cardiology ESC Working Group and the European Heart Rhythm. Association co‐endorsed by the Asia Pacific Heart Rhythm Society
  publication-title: Europace
– volume: 42
  start-page: 1528
  year: 2011
  end-page: 1533
  article-title: High NIHSS values predict impairment of cardiovascular autonomic control
  publication-title: Stroke
– volume: 35
  start-page: 1585
  year: 2012
  end-page: 1590
  article-title: Autonomic cardiac regulation during spontaneous nocturnal hypoglycemia in patients with type 1 diabetes
  publication-title: Diabetes Care
– ident: e_1_2_10_5_1
  doi: 10.1037/0033-295X.98.4.459
– ident: e_1_2_10_6_1
  doi: 10.3389/fphys.2011.00086
– ident: e_1_2_10_16_1
  doi: 10.1037/0735-7044.102.1.66
– ident: e_1_2_10_9_1
  doi: 10.1111/bph.13093
– ident: e_1_2_10_17_1
  doi: 10.1111/j.1476-5381.2010.00872.x
– ident: e_1_2_10_2_1
  doi: 10.1126/science.6166045
– ident: e_1_2_10_7_1
  doi: 10.1152/jappl.1993.75.5.2310
– ident: e_1_2_10_10_1
  doi: 10.1016/j.ejpain.2010.11.011
– ident: e_1_2_10_13_1
  doi: 10.1093/nar/gkx1121
– ident: e_1_2_10_26_1
  doi: 10.1016/j.hrthm.2016.02.006
– ident: e_1_2_10_11_1
  doi: 10.1016/j.jelectrocard.2012.08.001
– ident: e_1_2_10_23_1
  doi: 10.1016/j.jacc.2007.03.045
– ident: e_1_2_10_4_1
  doi: 10.1111/bph.13878
– ident: e_1_2_10_29_1
  doi: 10.1161/01.CIR.93.5.1043
– ident: e_1_2_10_21_1
  doi: 10.1097/00005344-199805000-00010
– ident: e_1_2_10_8_1
  doi: 10.1111/bph.13391
– ident: e_1_2_10_12_1
  doi: 10.1111/bph.14153
– ident: e_1_2_10_15_1
  doi: 10.1161/01.CIR.100.1.27
– ident: e_1_2_10_22_1
  doi: 10.1111/bph.12955
– ident: e_1_2_10_25_1
  doi: 10.1088/0967-3334/15/2/006
– ident: e_1_2_10_27_1
  doi: 10.1016/0002-9149(94)90400-6
– ident: e_1_2_10_19_1
  doi: 10.2337/dc11-2120
– ident: e_1_2_10_3_1
  doi: 10.1111/bph.13884
– ident: e_1_2_10_14_1
  doi: 10.1161/STROKEAHA.110.607721
– ident: e_1_2_10_20_1
  doi: 10.1161/01.CIR.0000047275.25795.17
– ident: e_1_2_10_24_1
  doi: 10.1152/japplphysiol.00446.2006
– ident: e_1_2_10_30_1
  doi: 10.1161/01.CIR.94.11.2850
– ident: e_1_2_10_28_1
  doi: 10.1093/europace/euv015
– ident: e_1_2_10_18_1
  doi: 10.1016/j.hrthm.2010.09.011
SSID ssj0014775
Score 2.3549433
Snippet Background and Purpose Increase in high‐frequency beat‐to‐beat heart rate oscillations by torsadogenic hERG blockers appears to be associated with signs of...
Increase in high-frequency beat-to-beat heart rate oscillations by torsadogenic hERG blockers appears to be associated with signs of parasympathetic and...
Background and PurposeIncrease in high‐frequency beat‐to‐beat heart rate oscillations by torsadogenic hERG blockers appears to be associated with signs of...
SourceID pubmedcentral
hal
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 3131
SubjectTerms Adult
Animals
Autonomic Nervous System
Dogs
EKG
Electrocardiography
Female
Heart - physiology
Heart Rate
Humans
Life Sciences
Macaca fascicularis
Male
Middle Aged
Models, Cardiovascular
Oscillations
Parasympathetic nervous system
Research Paper
Research Papers
Smoking
Young Adult
Title High‐frequency autonomic modulation: a new model for analysis of autonomic cardiac control
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fbph.14354
https://www.ncbi.nlm.nih.gov/pubmed/29723392
https://www.proquest.com/docview/2064075842
https://www.proquest.com/docview/2035243182
https://hal.umontpellier.fr/hal-01785431
https://pubmed.ncbi.nlm.nih.gov/PMC6031873
Volume 175
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB615cIF8SZQkEGo4tCgreOsEziVR7U8tYdW6gEp8mOsRYJs1d1F2hs_gd_IL2HGzqa7Kkhc8vI4D48n_hLPfAPwFAc6FCgx1_XA5UoZmddodK5L600ZtEfk_5CfPg9HJ-r9aXm6BS9XsTCJH6L_4caWEd_XbODGztaM3J5NnvNgr7bhCofWct4Gqcb9FILSOqUvYBbEg6rqaIXYjaevujEYbU_YFfIyzrzsLrkOY-M4dHQdrnUAUhwmjd-ALWxvwt44MVAv98XxRUDVbF_sifEFN_XyFnxhv47fP3-F8-RCvRRmMU-hyeL71He5vF4IIwhui5gmRxCsFabjLhHTsFbDxe5F6-TvfhtOjt4evx7lXYKF3FHrqBxdkMPK-OCML_jTEIPSQ8ucfNYra33hsXLDIqC3pTQulIXDOjgra0J5FRZ3YKedtngPhKtL6QJSKesCB1Z7OwhIO15TBZXBs1VLN65jH-ckGN-a1VcIKaWJSsngSS96lig3_ipE6urLmSR7dPix4WP0jqk4wv_HQQa7K202nWnOGhnnLgl3yQwe98VkVDxTYlqcLliGcCmdoiKZu0n5_aUk52kjVJmB3ugWG_eyWdJ-nUTi7pjRWxfUFrED_fvpmlfjUdy4__-iD-AqgbkqOSfuws78fIEPCTDN7aNoGLR88-7DH3BGFqA
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB615QCXijdpCxiEKg4N2jrOOkFcCqIKsK32sJV6QIr81CLRbNXuIu2tP6G_kV_CjJ1Nd1WQOOXhcR4eT_zFnvkG4I3rSZ857lJZ9kwqhOJp6ZRMZa6tyr20ztE85NFxvzoRX0_z0zX4sIiFifwQ3YQbWUb4XpOB04T0kpXr8_E7Gu3FOtwRiMvJoY-LYbeGIKSM-QuIBnG_KFpeIfLj6aqujEbrY_KFvA00b_tLLuPYMBAd3ofNFkGyg6jyB7DmmoewO4wU1PM9NrqJqLrcY7tseENOPX8E38mx4_fVtb-IPtRzpmbTGJvMzia2Teb1nimGeJuFPDkMcS1TLXkJm_ilGib0L9xGh_fHcHL4efSpStsMC6nB1hGpM573C2W9UTajf0PnhexrIuXTVmhtM-sK08-8szrnyvg8M670RvMSYV7hsiew0Uwa9wyYKXNuvMNSinN2PS2t7nmHB1ZiBZHA20VL16alH6csGD_rxW8IKqUOSkngdSd6Hjk3_iqE6urKiSW7OhjUdA4_MgWF-P_aT2Bnoc26tc3LmofFSwRePIFXXTFaFS2VqMZNZiSDwBQvUaDM06j87lacErUhrExArnSLlWdZLWl-jANzd0jpLTNsi9CB_v129cdhFXa2_l_0JdytRkeDevDl-Ns23ENkV0RPxR3YmF7M3HNET1P9IhjJH-84GRo
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB61RUJcqvIOFDAIVRwatHWcdQKn8lgtUKocWqkHpMhPbaU2u2p3K-2Nn8Bv5JcwY2fTXRUkTnl4nIfHY3-JZ74BeO160meOu1SWPZMKoXhaOiVTmWurci-tc_Qf8vthf3gsvp7kJ2vwfhELE_khuh9uZBlhvCYDn1i_ZOR6MnpLk71Yh1u02EdWyUXVLSEIKWP6AmJB3CuKllaI3Hi6qiuT0fqIXCFv4syb7pLLMDbMQ4Mt2GwBJNuPGr8La665BztVZKCe77Kj64Cqy122w6prbur5ffhBfh2_f_7yF9GFes7UbBpDk9n52La5vN4xxRBus5AmhyGsZarlLmFjv1TDhO6F2-jv_gCOB5-PPg7TNsFCarB1ROqM5_1CWW-UzejT0Hkh-5o4-bQVWtvMusL0M--szrkyPs-MK73RvESUV7jsIWw048Y9BmbKnBvvsJTCnF1PS6t73uGBlVhBJPBm0dK1adnHKQnGWb34CkGl1EEpCbzqRCeRcuOvQqiurpxIsof7BzWdwzGmoAj_q70EthfarFvTvKx5WLvEDsMTeNkVo1HRSolq3HhGMohL8RIFyjyKyu9uxSlPG6LKBORKt1h5ltWS5nQUiLtDRm-ZYVuEDvTvt6s_VMOw8-T_RV_A7erToD74cvjtKdxBXFdEP8Vt2JhezNwzxE5T_TzYyB8hGhhD
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High%E2%80%90frequency+autonomic+modulation%3A+a+new+model+for+analysis+of+autonomic+cardiac+control&rft.jtitle=British+journal+of+pharmacology&rft.au=Champ%C3%A9roux%2C+Pascal&rft.au=Fesler%2C+Pierre&rft.au=Jud%C3%A9%2C+Sebastien&rft.au=Richard%2C+Serge&rft.date=2018-08-01&rft.pub=John+Wiley+and+Sons+Inc&rft.issn=0007-1188&rft.eissn=1476-5381&rft.volume=175&rft.issue=15&rft.spage=3131&rft.epage=3143&rft_id=info:doi/10.1111%2Fbph.14354&rft_id=info%3Apmid%2F29723392&rft.externalDocID=PMC6031873
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-1188&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-1188&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-1188&client=summon